The skin on your décolletage, upper arms, and inner thighs ages faster than the skin on your face. The reasons are mechanical; the correction is chemical; the protocol is older and better-evidenced than most premium body care lets on.
The answer in one paragraph
Crepey skin is a thin, finely wrinkled body skin texture caused by the cumulative breakdown of collagen and elastin in the dermis, combined with disordered corneocyte turnover at the surface. It typically appears on the upper arms, inner thighs, and décolletage, often by the early forties, and progresses with photoageing, hormonal change, and weight fluctuation. The condition is not synonymous with general skin ageing; it is a specific surface presentation, and it is one of the few body texture concerns that responds meaningfully to topical intervention. A 1996 study published in the Journal of the American Academy of Dermatology documented an approximate 25% increase in forearm skin thickness after six months of topical alpha-hydroxy acid application, with measurable improvements in elastin quality and dermal collagen density. The evidence has been replicated and extended since. The protocol works. The marketing rarely catches up to the science.
Why body skin ages faster than facial skin
Facial skin receives the bulk of the world's skincare attention and the bulk of the consumer's spending. Body skin receives moisturiser. The asymmetry is reflected in the skin itself. By the time most women reach their early forties, facial skin often looks measurably younger than the skin on the décolletage, upper arms, or inner thighs.
Three structural factors explain the difference.
The first is treatment intensity. Facial routines often include retinoids, vitamin C, sunscreen applied daily, and active exfoliation. Body routines often include none of these. The cumulative gap, applied across decades, produces a structural divergence in how the two surfaces age.
The second is photoexposure pattern. The décolletage, the back of the hands, and the outer forearms receive substantial UV exposure across a lifetime, often without sunscreen application. UV radiation degrades elastin and collagen in the dermis, and the damage compounds. The 1996 Ditre study and subsequent 2024 reviews published in Clinical, Cosmetic and Investigational Dermatology document this mechanism in detail.
The third is corneocyte turnover. Surface cell renewal slows with age, and slows more on body skin than facial skin to begin with. The stratum corneum thickens, surface texture coarsens, and the cumulative effect produces the dry, paper-like finish that gives crepey skin its name. Corneocyte turnover is the variable that responds most quickly to topical AHA intervention.
What crepey skin actually is, biologically
Crepey skin is the visible expression of three simultaneous processes:
- Dermal collagen depletion. Collagen, the structural protein that gives skin its firmness, declines by approximately 1% per year from the mid-twenties onward. The decline accelerates around perimenopause, when oestrogen withdrawal removes a key signal supporting collagen synthesis.
- Elastin fragmentation. Elastin fibres, which give skin its recoil after stretching, are slowly degraded by cumulative UV exposure. Once damaged, elastin does not fully repair. The Cleveland Clinic dermatology reference describes the analogy of an elastic waistband that gradually loses its return.
- Surface disorder. The stratum corneum, the outermost layer of the epidermis, becomes thicker, drier, and less organised with age. Corneocytes accumulate, the surface coarsens, and what should be a smooth optical surface scatters light into the visible roughness of crepey texture.
The first two processes are dermal. The third is surface. Topical AHAs operate on all three, more directly on the third, indirectly but measurably on the first two through low-grade dermal signalling.
What the peer-reviewed literature shows
The strongest body of evidence for topical correction of crepey body skin comes from controlled studies on photoaged forearm skin. The most-cited is Ditre et al., 1996, Journal of the American Academy of Dermatology, in which patients applied an AHA lotion to one forearm and a placebo to the other across six months. The treated forearms showed approximately 25% increased skin thickness, improved elastin quality, increased dermal collagen density, and increased acid mucopolysaccharide content. The placebo forearms did not change.
Subsequent work has refined the protocol. Stiller et al. demonstrated that 8% glycolic and 8% lactic acid creams applied twice daily for 22 weeks produced measurable improvement in photodamage severity on the face and forearms in a vehicle-controlled trial. A 2024 comprehensive review in Clinical, Cosmetic and Investigational Dermatology synthesised the cumulative literature and confirmed that AHAs, particularly glycolic acid at clinical concentrations, produce consistent improvements in dermal thickness, elastin quality, and surface texture in photoaged skin.
The mechanism is now well-characterised: AHAs accelerate corneocyte turnover, normalise the stratum corneum, increase glycosaminoglycan content in the dermis, and stimulate low-grade collagen synthesis through a controlled inflammatory signal. The clinical outcome, given consistent application across the published time frames, is the gradual return of dermal thickness and surface smoothness.
Why concentration and pH determine outcomes for body skin
The studies that produced the 25% skin thickness data used AHA concentrations of 8% to 25% on body skin, sustained across 22 weeks to 6 months, with formulation pH within the therapeutic window. Below these thresholds, the published outcomes do not appear. This is the source of the disconnect between dermatology evidence and the body care marketplace: most body creams marketed for "firming" or "anti-ageing" do not contain AHAs at concentrations or pH levels capable of producing the documented effects.
For dedicated correction of crepey body skin, the dermatology benchmark is glycolic acid at 10% to 12%, buffered to pH 3.6 to 4.0, applied consistently three to four times weekly. Below 10%, the formulation behaves as a surface humectant rather than a resurfacing active. Above pH 4.0, the active fraction collapses and the percentage on the label becomes decorative.
The realistic timeline
Crepey skin does not change in days, and it does not change in weeks. The published clinical timelines run from 12 weeks for surface improvement to 6 months for measurable dermal change. Most users report a noticeable softening of surface texture within 4 to 8 weeks of consistent application, followed by gradual cumulative improvement in firmness across the following 4 to 5 months. The 25% skin thickness change reported in the Ditre study took six months. Less time produces less change.
The condition will return if treatment is discontinued, because the underlying processes (collagen decline, photoexposure, slowed turnover) continue regardless of any single intervention. Sustained use is the realistic frame. The frame is closer to dental hygiene than to a course of antibiotics: maintenance, not cure.
The case for face-grade body care
The most useful reframe for women in their forties, fifties, and sixties is to apply to body skin the same logic that has produced visible results on facial skin for the past three decades. That logic is: identify the active class with the strongest evidence (AHAs, retinoids), apply at clinical concentration, sustain consistently, protect against the photoexposure that drove the damage in the first place.
The body version of this logic is identical, scaled to the thicker stratum corneum of body skin. A 12% glycolic acid body lotion at therapeutic pH is the body equivalent of what facial AHAs at 5% to 10% have delivered for years on facial skin. The same chemistry, calibrated for the different substrate.
The 12% AHA Glycolic Acid Body Lotion is formulated to these specifications: 12% glycolic acid, buffered pH 3.6 to 4.0, supported by urea for keratin compaction and humectant action, and niacinamide for barrier integrity and post-inflammatory pigmentation. The combination operates on all three processes that produce crepey skin: surface disorder, keratin accumulation, and the low-grade inflammation that signals the dermis to reorganise.
Frequently asked questions
What causes crepey skin?
Crepey skin is caused by three simultaneous processes: gradual depletion of dermal collagen (which begins in the mid-twenties and accelerates around perimenopause), cumulative UV-induced fragmentation of elastin fibres in the dermis, and slowed corneocyte turnover at the skin surface. The combination produces a thin, finely wrinkled texture most commonly on the upper arms, inner thighs, and décolletage, often appearing earlier on body skin than on facial skin.
Can crepey skin be reversed?
Crepey skin can be measurably improved with consistent topical intervention. A 1996 study in the Journal of the American Academy of Dermatology documented an approximate 25% increase in forearm skin thickness after six months of topical alpha-hydroxy acid application, alongside measurable improvements in elastin and collagen quality. The reversal is partial and cumulative; sustained treatment maintains the improvement.
Does glycolic acid work on crepey skin?
Yes, at sufficient concentration and pH. Peer-reviewed clinical trials at glycolic acid concentrations of 8% to 25%, applied across 22 weeks to 6 months, have shown measurable improvements in photoaged skin thickness, elastin quality, and surface texture. The dermatology benchmark for at-home body application is 10% to 12% glycolic acid buffered to pH 3.6 to 4.0, applied three to four times weekly.
How long does it take to see results on crepey arms?
Surface softening typically becomes noticeable within 4 to 8 weeks of consistent application. Measurable change in dermal thickness, as documented in clinical trials, requires sustained application across approximately 6 months. The 25% skin thickness improvement reported in the published literature took 6 months of twice-daily application. Faster improvement is possible at the surface; dermal change requires the full timeline.
What ingredients are best for crepey skin on the body?
The strongest evidence base supports alpha-hydroxy acids, particularly glycolic acid at 10% to 12% concentration buffered to pH 3.6 to 4.0. Supportive ingredients with consistent evidence include niacinamide (2% to 5%) for barrier integrity and pigmentation modulation, and urea (10% or higher) for complementary keratolytic action and humectant function. Fragrance-free formulation reduces sensitiser load on the increasingly reactive skin of the perimenopausal years.
References
- Ditre CM, Griffin TD, Murphy GF, et al. Effects of alpha-hydroxy acids on photoaged skin: a pilot clinical, histologic, and ultrastructural study. Journal of the American Academy of Dermatology. 1996;34(2 Pt 1):187-195. doi:10.1016/s0190-9622(96)80110-1
- Stiller MJ, Bartolone J, Stern R, et al. Topical 8% glycolic acid and 8% L-lactic acid creams for the treatment of photodamaged skin. A double-blind vehicle-controlled clinical trial. Archives of Dermatology. 1996;132(6):631-636.
- Tang SC, Yang JH. Dual effects of alpha-hydroxy acids on the skin. Molecules. 2018;23(4):863. doi:10.3390/molecules23040863
- Evaluating the Efficacy and Safety of Alpha-Hydroxy Acids in Dermatological Practice: A Comprehensive Clinical and Legal Review. Clinical, Cosmetic and Investigational Dermatology. 2024. doi:10.2147/CCID.S453243
About The Lotion
The Lotion is an Australian clinical body skincare house formulating to the six-marker standard: at least 10% AHA concentration, buffered pH 3.6 to 4.0, supportive humectants, fragrance-free composition, no sensitiser load, and a vehicle calibrated for stratum corneum delivery. The brand publishes a single product: a 12% AHA Glycolic Acid Body Lotion with urea, niacinamide, and shea butter, formulated and manufactured in Australia.
The Lotion Editorial. Reviewed quarterly. Last updated May 2026.
